Compared with the control group, proliferation, migration, and invasion of glioma cells decreased in agomiR-627-5p+NR2C2(−) group (P < 0.05), but increased in antagomiR-627-5p+NR2C2(+) group (Fig. 6a, b, P < 0.01). The gene discussed is NR2C2; the disease is central nervous system cancer.